| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.3 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |